Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Company Overview More
Tengsheng Boyao Biotechnology Co., Ltd. is a biotechnology company headquartered in China and the United States, mainly engaged in infectious disease therapy research and development business. The company's products are used in infectious diseases (such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multidrug-resistant (MDR) or extensively drug-resistant (XDR) Gram-negative bacteria infections) and other diseases with significant public health burdens, such as central nervous system (CNS) diseases. The company also develops treatments for COVID-19 and others.
CEO: Zhi HONG
Market: Hong Kong motherboard
Futu Hot List
HKUSCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Futubull > Quotes > 02137 BRII-B > Key Indicators
02137 BRII-B
8.310+0.210+2.59%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(FY)2019/12/31
Per Share IndicaTor
Operating Cash Flow Per Share
-- -1.4934 -- -1.2166 -- -- -- --
Cash Flow Per Share
-- 3.1837 -- 0.8435 -- -- -- --
Net Asset Per Share
-- 5.6764 -- -9.3618 -- -- -- --
Basic Earning Per Share
-56.89% -11.5949 -- -17.8589 -126.72% -7.3903 -- -3.2597
Diluted  Earning Per Share
-56.89% -11.5949 -- -17.8589 -126.72% -7.3903 -- -3.2597
Profitability
ROE
-- -503.408% -- -- -- -- -- --
ROA
-62.21% -171.938% -- -202.069% -- -105.999% -- --
Yield Quality
Capital Structure
Debt Assets Ratio
-96.5% 8.319% -- 377.752% 49.38% 237.443% -- 158.952%
Equity Multipler
-- 1.0804 -- -- -- -- -- --
Debt Equity Ratio
-- 9.073% -- -- -- -- -- --
Current Assets To tatal Assets
9.67% 94.525% -- 89.202% 1.18% 86.190% -- 85.187%
Non Current Assets To Total Assets
-60.35% 5.475% -- 10.798% -6.77% 13.810% -- 14.813%
Current Liabilities To tatal Liabilities
389.01% 93.433% -- 2.430% 410.11% 19.107% -- 3.746%
Non Current Liabilities To Total Liabilities
-91.88% 6.567% -- 97.570% -15.96% 80.893% -- 96.254%
Solvency
Current Ratio
540.15% 12.1617 -- 9.7178 -86.72% 1.8998 -- 14.3083
Operating Profit To Current Liabilities
-569.81% -14.926 -- -19.2688 73.48% -2.2284 -- -8.4014
Operrating Cash Flow To Current Liabilities
-346.4% -3.1329 -- -3.9283 35.44% -0.7018 -- -1.0871
Share Equity Without Minority Interest To Total Liabilities
2027.08% 11.1266 -- -0.7345 -55.68% -0.5774 -- -0.3709
Operating Cash Flow To Total Liabilities
-2082.91% -2.9272 -- -0.0955 -229.32% -0.1341 -- -0.0407
Operating Profit To Total Liabilities
-3175.43% -13.9458 -- -0.4682 -35.3% -0.4258 -- -0.3147
Operating Capacity
Growth Ability
Other Indicators
Currency Unit
HKDHKDHKDHKD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Back to the Top